Oncolytic measles virus induces tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated cytotoxicity by human myeloid and plasmacytoid dendritic cells

Attenuated measles virus (MV) is currently being evaluated in clinical trials as an oncolytic therapeutic agent. Originally used for its lytic activity against tumor cells, it is now admitted that the effectiveness of MV also lies in its ability to initiate antitumor immune responses through the act...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oncoimmunology
Hauptverfasser: Achard, Carole, Guillerme, Jean-Baptiste, Bruni, Daniela, Boisgerault, Nicolas, Combredet, Chantal, Tangy, Frédéric, Jouvenet, Nolwenn, Grégoire, Marc, Fonteneau, Jean-François
Format: Artigo
Sprache:Inglês
Veröffentlicht: Taylor & Francis 2016
Schlagworte:
Original Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5283625/
https://ncbi.nlm.nih.gov/pubmed/28197384
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2016.1261240
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge